Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption-Reference-Cited by-同舟云学术

Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption

Published:2010-03 Issue:10 Volume:285 Page:7619-7632
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Zhao Wei-Qin,Santini Francesca,Breese Robert,Ross Dave,Zhang Xiaohua Douglas,Stone David J.,Ferrer Marc,Townsend Matthew,Wolfe Abigail L.,Seager Matthew A.,Kinney Gene G.,Shughrue Paul J.,Ray William J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference85 articles.

1. Alzheimer's Disease Is a Synaptic Failure

2. Synaptic slaughter in Alzheimer's disease

3. Synaptic Pathology of Alzheimer's Diseasea

4. High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation

5. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early hippocampal hyperexcitability and synaptic reorganization in mouse models of amyloidosis;iScience;2024-09

2. Amyloid-β Causes NMDA Receptor Dysfunction and Dendritic Spine Loss through mGluR1 and AKAP150-Anchored Calcineurin Signaling;The Journal of Neuroscience;2024-08-12

3. AMPA Receptors Endocytosis Inhibition Attenuates Cognition Deficit Via c-Fos/BDNF Signaling in Amyloid β Neurotoxicity;Experimental Aging Research;2024-07-30

4. Role of Amyloidogenic and Non‐Amyloidogenic Protein Spaces in Neurodegenerative Diseases and their Mitigation Using Theranostic Agents;ChemBioChem;2024-06-14

5. Photobiomodulation in experimental models of Alzheimer’s disease: state-of-the-art and translational perspectives;Alzheimer's Research & Therapy;2024-05-21